James Hassard
Corporate Officer/Principal presso CRINETICS PHARMACEUTICALS, INC.
Patrimonio netto: 1 M $ in data 30/04/2024
Profilo
James Hassard is currently the Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. He previously held the position of Chief Commercial Officer at Arrowhead Pharmaceuticals, Inc. from 2020 to 2021.
Prior to that, he was the Vice President-Marketing at Medivation LLC (California) and the General Manager at Amgen BIO Farmaceutica Ltda.
From 2016 to 2020, he served as the Senior Vice President-Marketing & Market Access at Coherus BioSciences, Inc. Mr. Hassard holds an MBA from Nova Southeastern University, Inc. and an undergraduate degree from the University of Toronto.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
15/04/2024 | 29 259 ( 0.04% ) | 1 M $ | 30/04/2024 |
Posizioni attive di James Hassard
Società | Posizione | Inizio |
---|---|---|
CRINETICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2022 |
Precedenti posizioni note di James Hassard
Società | Posizione | Fine |
---|---|---|
ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 23/08/2021 |
COHERUS BIOSCIENCES, INC. | Vendite & Marketing | 01/01/2020 |
Amgen BIO Farmaceutica Ltda | Corporate Officer/Principal | - |
MEDIVATION INC | Vendite & Marketing | - |
Formazione di James Hassard
Nova Southeastern University, Inc. | Masters Business Admin |
University of Toronto | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
COHERUS BIOSCIENCES, INC. | Health Technology |
CRINETICS PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Amgen BIO Farmaceutica Ltda |
- Borsa valori
- Insiders
- James Hassard